I don’t do this often… (rare penny stock prediction)

Editors Note: Our colleague and Casey Research analyst Nick Giambruno just made a bold stock market prediction for the coming year that could generate a big windfall for early investors. We think you'll find it interesting...   Dear Reader, I don't often make big predictions. But today I'm going out on a limb... Because this tiny $5 biotech stock has all the makings of a massive winner. They are breezing through the FDA approval process with a "holy serum" treatment that could be worth a total of $8.1 billion. The anticipated FDA announcement may come as early as 9:31 AM tomorrow... And it could send this tiny stock on a 4,100% run. Considering what's at stake here... I wouldn't be surprised if this is the biggest biotech winner of 2021. Go here to get the full story — before 9:31 am tomorrow. Regards, Nick Giambruno Chief Analyst, Casey Research P.S. One more thing... this $5 company isn't a one-trick pony. They are angling for another $6 billion market with one more "holy serum" treatment in the pipeline. And it could be worth a fortune to early investors. More details here. © 2020 Legacy Research Group. All rights reserved. 55 NE 5th Avenue, Delray Beach, FL 33483, USA. To ensure our emails continue reaching your inbox, please add our email address to your address book. If you no longer wish to hear about this opportunity you can unsubscribe here.